Categories Technology

Elon Musk might sell his Tesla stock to fund space travel in the future

Tesla chief Elon Musk says that in about 20 years, he plans to sell a ‘major’ stake in Tesla to finance the Mars colonization plans by SpaceX. The CEO of two billion-dollar companies – Tesla and SpaceX – took to Twitter to announce this.

Earlier, Musk wanted to leave Tesla’s head role to focus on SpaceX.

Even though it was said to come to pass when Model 3 achieves volume production, the billionaire seemed to have ramped up his involvement in the electric car maker. But his aim looks to be the same – to benefit SpaceX.

Tesla vehicle production and deliveries

According to the new CEO compensation plan at Tesla (TSLA), Musk looks to receive a multi-billion dollar payout. While it would significantly spike his already substantial stake in the automaker, Elon plans to drive it all back to his love for space.

The CEO on Friday tweeted his long-term plan – just like his 2016 sale of about 2.8 million Tesla shares to pay taxes and donate to charity – he would sell a huge chunk in about twenty years and use it to aid space exploration efforts in SpaceX.

 

 


While selling shares is almost always a red signal in the Street, the eccentric billionaire’s explanation for a stock sale twenty years into the future seem to have mitigated that. One more feather in the cap of norm-defying Musk.

Related: How Elon Musk tweaked the system with Tesla

In the said timeline of two decades, it is hoped that Tesla would achieve a sort-of stable and good position in the market for Musk’s stake sale to have much effect. Meanwhile, the prospects of space travel into the future looks more and more achievable. It looks like Musk has it all sorted out. Or is he just bluffing?

Related: Elon Musk admits to Tesla Model 3 braking issue, confirms firmware fix
Related: Elon Musk increases his stake in Tesla; buys 72,500 shares

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top